menu close
Access The Private Market

Explore Companies

With a comprehensive suite of private market programming and liquidity solutions, Nasdaq Private Market can help unlock the power of data for market participants worldwide.

TRexBio

Develops therapeutics for immune diseases by analyzing tissue and computational biology to identify drug targets that restore immune balance.

Trialspark

Tech-driven pharmaceutical company accelerates drug development by acquiring clinical-stage treatments and optimizing their path to market.

TRIANA Biomedicines

Develops molecular glue therapeutics to modify disease proteins using a target-first platform that identifies function-altering molecules.

TripleBar

Creates products that nourish, heal, and sustain both people and the planet.

TrueBinding

Develops monoclonal antibody therapeutics targeting neurodegenerative and metabolic diseases, focusing on disease-modifying treatments.

Truvian

A medical technology company that creates automated blood testing analyzers, providing rapid and accurate diagnostic results to enhance patient care.

Tune Therapeutics

A biotechnology company that develops epigenome editing therapies, enabling precise gene regulation to address complex diseases.

TurtleTree

Biotech company focused on creating sustainable and innovative nutrition solutions.

TwinStrand Biosciences

A genomics company that offers ultra-accurate DNA sequencing technology.

Ultima Genomics

Developing advanced genomic sequencing technologies.

Variant Bio

Biotechnology company leverages human genetic data to develop targeted therapies for complex diseases and advance personalized medicine.

Verge Genomics

Drug discovery company that combines artificial intelligence and neuroscience.

Vesalius Therapeutics

Biotech company develops RNA-based therapies for complex diseases by targeting the human transcriptome to advance precision medicine.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Vizgen

A leader in spatially resolved, single-cell transcriptomics, the company provides innovative solutions for visualizing gene expression in situ.

WaveBreak

Develops small-molecule drugs targeting toxic protein formations in neurodegenerative diseases using innovative drug discovery platform.

Wugen

Develops off-the-shelf NK and CAR-T cell therapies engineered from healthy donors to treat various cancers.

ZetaGen Therapeutics

Clinical-stage biotech company developing targeted therapies for bone cancers, using proprietary platform for local treatment delivery.